PROSPECTS AND OPPORTUNITIES
Late-peaking 2024-25 respiratory illness season ensures stong start to the forecast period
Value sales of cough, cold and allergy (hay fever) remedies are expected to rise over the forecast period, benefiting from elevated demand after a late-peaking 2024-25 respiratory illness season and a sharp uptick in flu at the start of 2025, which kept consumers restocking decongestants, pharyngeal preparations and paediatric lines. National surveillance reported flu activity rising in early 2025 and a spring peak, while EU/EEA monitoring also showed increasing circulation, supporting a larger cough-and-cold market base going into the forecast years.
Online pharmacies offer real-time stock visibility, price comparison, and delivery to rural areas
Estonia’s 100% digital e-prescription backbone and mature e-health stack let doctors, pharmacists and patients manage medicines entirely online, enabling frictionless refills, adherence checks and click-and-collect during viral spikes. Community pharmacies are deeply integrated with national e-systems, and distance selling of non-prescription medicines is permitted for licensed internet pharmacies, which has broadened the online assortment and driven service innovation.
Market increasingly digital, regulation-driven, and aligned with sustainable packaging practices
Two key regulatory baselines will shape the forecast period. Firstly, in Estonia, only licensed internet pharmacies are permitted to sell medicines online, and they must display the EU common verification logo, an important trust signal.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Estonia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Estonia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Cough, Cold and Allergy (Hay Fever) Remedies in Estonia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Estonia?
- Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in Estonia?
- How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in Estonia?
- How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in Estonia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Cough, Cold and Allergy (Hay Fever) Remedies in Estonia - Category analysis
KEY DATA FINDINGS
Uptick in paediatric respiratory illnesses drives growth in 2025
McNeil leads with its dual-action Sudafed brand
Pharmacies benefit from many higher-value SKUs being pharmacy-only
Late-peaking 2024-25 respiratory illness season ensures stong start to the forecast period
Online pharmacies offer real-time stock visibility, price comparison, and delivery to rural areas
Market increasingly digital, regulation-driven, and aligned with sustainable packaging practices
Consumer Health in Estonia - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Cough, Cold and Allergy (Hay Fever) Remedies
- Antihistamines/Allergy Remedies (Systemic)
-
- Paediatric Allergy Remedies
- Paediatric Cough/Cold Remedies
- Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
- Cough Remedies
-
- Nasal Sprays
- Oral Decongestants
- Inhalant Decongestants
- Decongestant Rubs
- Nasal Decongestant Drops
- Nasal Decongestant Plasters
- Medicated Confectionery
- Pharyngeal Preparations
Cough, Cold and Allergy (Hay Fever) Remedies
This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!